Glucose transporter 2 (Glut2) and Glucokinase, which respectively mediate two early rate-controlling steps in the glycolytic pathway, glucose uptake and carbon 6 phosphorylation respectively were also investigated
GLP-1 medications are typically dosed weekly (semaglutide, tirzepatide) while BPC-157 is dosed daily
Significantly elevated homocysteine has been observed in people suffering with cardiovascular disease, stroke, neurodegeneration (Nelson et al, 2016) and frailty in old age (Guaita et al, 2021) and elevated homocysteine is associated with a reduced blood flow to the small vessels in the brain (reduced microcirculation) (Hassan et al, 2004) which is an important connection because a reduced microcirculation may increase the risk of developing Alzheimers disease, amyotrophic lateral sclerosis (ALS) or Parkinsons disease (Erdener and Dalkara, 2019)
Therefore, we evaluated the effect of the GLP-1R agonist, liraglutide, on cell GLP-1 production and PC1/3 expression using a tamoxifen-inducible cellspecific GLP-1RKO mouse model (9, 25)
In humans, the major site of SCFAs and butyrate production is the colon, from where total SCFAs are drained into the portal blood with much higher concentration (375mol/l) than in peripheral blood (79mol/l) (29)
Biomed Pharmacother 57:145155
